CNE1000035K5
CNE1000035K5
PHARMABLOCK
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 11.93B EUR | 8.56B EUR | 8.48B EUR | 9.02B EUR |
Enterprise Value | 10.28B EUR | 8.03B EUR | 8.21B EUR | 8.6B EUR |
Valuation Multiples | ||||
Trailing P/E | 53.69x | 50.4x | 54.35x | 63.12x |
Forward P/E | 40.81x | -- | -- | -- |
Price to Sales | 5.64x | 5.3x | 5.55x | 6.11x |
Price to Book | 2.6x | 1.87x | 1.54x | 1.43x |
EV/Revenue | 4.86x | 4.97x | 5.37x | 5.83x |
EV/EBITDA | 28.66x | 38x | 37.52x | 39.25x |
Price to FCF (P/FCF) | 113.72x | 149.86x | 45.6x | 20.2x |
EV/FCF | 98x | 140.65x | 44.18x | 19.25x |
FCF Yield | 0.88% | 0.67% | 2.19% | 4.95% |